CIK 0001684144 · Non-accelerated filer<br>Smaller reporting company
Zomedica Corp.
Sign in to watch- Ticker
- ZOMDF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Alberta, Canada
- Entity type
- operating
- Phone
- (734) 369-2555
- Business address
- 1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
- Former names
- Zomedica Pharmaceuticals Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-13 | Blair Anthony K COO | Purchase | +150,000 | $0.14 | $21K | 150,000 |
| 2024-05-13 | HEATON LARRY C II CEO | Purchase | +100,000 | $0.14 | $14K | 300,000 |
| 2023-12-15 | POWERS JOHNNY D Director | Purchase | +100,000 | $0.17 | $17K | 1,950,000 |
| 2023-12-15 | POWERS JOHNNY D Director | Purchase | +100,000 | $0.17 | $17K | 1,950 |
| 2023-11-17 | POWERS JOHNNY D Director | Purchase | +100,000 | $0.17 | $17K | 1,850,000 |
| 2023-11-17 | HEATON LARRY C II CEO | Purchase | +100,000 | $0.17 | $17K | 200,000 |
| 2023-11-15 | POWERS JOHNNY D Director | Purchase | +150,000 | $0.17 | $26K | 1,750,000 |
| 2023-11-07 | Klass Russell Kevin Vice President of Sales | Grant or award · Option to Buy Common Stock | +2,000,000 | 2,000,000 | ||
| 2023-11-07 | Klass Russell Kevin Vice President of Sales | Grant or award · Option to Buy Common Stock | +2,000,000 | 2,000,000 | ||
| 2023-05-26 | HEATON LARRY C II CEO | Purchase | +100,000 | $0.19 | $19K | 100,000 |
| 2023-05-25 | POWERS JOHNNY D Director | Purchase | +100,000 | $0.19 | $19K | 1,600,000 |
| 2023-03-16 | Donato Peter Chief Financial Officer | Grant or award · Option to Buy Common Stock | +5,000,000 | 5,000,000 | ||
| 2022-12-09 | POWERS JOHNNY D Director | Grant or award · Options to Buy Common Stock | +1,465,727 | 1,465,727 | ||
| 2022-12-09 | Cohen Robert Director | Grant or award · Options to Buy Common Stock | +1,465,727 | 1,465,727 | ||
| 2022-12-09 | Nichols Pamela Director | Grant or award · Options to Buy Common Stock | +231,431 | 231,431 | ||
| 2022-12-09 | Whelan Sean Director | Grant or award · Options to Buy Common Stock | +1,157,153 | 1,157,153 | ||
| 2022-12-09 | Rowe Jeffrey M Director | Grant or award · Options to Buy Common Stock | +1,465,727 | 1,465,727 | ||
| 2022-12-09 | Williams Rodney James Director | Grant or award · Options to Buy Common Stock | +1,465,727 | 1,465,727 | ||
| 2022-12-09 | MACLEOD CHRISTOPHER ROSS Director | Grant or award · Options to Buy Common Stock | +1,465,727 | 1,465,727 | ||
| 2022-10-04 | HEATON LARRY C II CEO | Grant or award · Option to buy common stock | +4,000,000 | 4,000,000 |
Page 6 of 8 · 143 trades